Carregando...

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma

BACKGROUND: Aberrant activation of Axl is implicated in the progression of hepatocellular carcinoma (HCC). We explored the biologic significance and preclinical efficacy of Axl inhibition as a therapeutic strategy in sorafenib-naive and resistant HCC. METHODS: We evaluated Axl expression in sorafeni...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Principais autores: Pinato, David J., Brown, Matthew W., Trousil, Sebastian, Aboagye, Eric O., Beaumont, Jamie, Zhang, Hua, Coley, Helen M., Mauri, Francesco A., Sharma, Rohini
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461770/
https://ncbi.nlm.nih.gov/pubmed/30765873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0373-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!